Commercialization of cavitation-enhancing nanodroplets for DNA sample fragmentation in NGS applications
Commercialization of cavitation-enhancing nanodroplets for DNA sample fragmentation in NGS applications
批准号:
10081304
负责人:
Sandeep Kasoji
金额:
$84.47万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-07-05 至 2022-08-31
关键词:
AcousticsAddressBase PairingBathingBiologicalBiotechnologyCell LineDNADNA FragmentationDNA Sequencing FacilityDevelopmentDigestionDue ProcessEnhancement TechnologyEquipmentExclusionExposure toFaceFluorocarbonsFreezingGenerationsGenesGeneticGenomic DNAGenomicsGoldHeadHealth TechnologyHuman Genome ProjectIndividualIndustryIndustry StandardInterviewLarge-Scale SequencingLegal patentLengthLibrariesMethodsModificationOutputPainPerformancePhasePositioning AttributePregnancy TestsPreparationPriceProductionProtocols documentationPublic HealthQuality ControlReagentReproducibilityRiskSalesSamplingShipsSignal TransductionSingle Nucleotide PolymorphismSmall Business Innovation Research GrantSonicationStandardizationTechnologyTestingTimeTransistorsTubeUltrasonicsValidationWorkcommercializationcostdesignexomegene therapygenetic analysisgenetic testinghuman DNAimprovedinnovationinsertion/deletion mutationinstrumentnanoDropletnext generation sequencingnovelpersonalized diagnosticsprecision medicineproduct developmentprototyperesearch and developmentscale upsuccessvalidation studieswhole genome
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
The completion of the Human Genome Project has established NGS as the gold standard technology for
personalized/precision medicine and diagnostics. Genetic testing kits are now as readily available as pregnancy
test kits, and advances in genetic analysis, gene therapy, and genetic modification in the 21st century promise to
parallel the development of transistors and integrated circuits in the 20th century. The challenge is that technology
for preparing biological samples for sequencing has not maintained a similar rapid advancement to gene
sequencing. Fragmentation of DNA randomly without bias is an essential, but difficult step in the preparation of
genomic DNA for NGS applications. A narrow range of DNA fragment lengths is required for sequencing, and
inefficient or inconsistent fragmentation will result in incomplete or excluded reads, corrupting the sequencing.
Sonication, which fragments DNA through cavitation, is the gold standard for DNA fragmentation.
However, our customer discover interviews have reinforced that this is a significant pain point in their sample
preparation process due to its low throughput and inconsistency, particularly for industry developing large-scale
sequencing efforts.
We have invented a novel nanodroplet reagent that enhances cavitation from an acoustic sonicator, and
greatly improves consistency and reduces time and acoustic power requirements for DNA fragmentation.
Triangle Biotechnology has licensed the patents describing this cavitation enhancing technology.
We have achieved milestones proposed in Phase I, demonstrating product and technical feasibility. With
this SBIR Phase II, we will perform key R&D tasks, product development, and validation studies to prepare for
commercialization. Success of this project will enable a novel commercial solution for addressing market
pain points: substantially improving throughput and consistency of DNA fragmentation for NGS sample
preparation while reducing cost.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Improving diagnostic sensitivity for difficult-to-lyse microbial samples with nanodroplet technology
-
批准号:10484601
-
项目类别:
-
资助金额:$100.0万
-
财政年份:2020
-
负责人:Sandeep Kasoji
-
依托单位:
Improving diagnostic sensitivity for difficult-to-lyse microbial samples with nanodroplet technology
-
批准号:10081308
-
项目类别:
-
资助金额:$25.21万
-
财政年份:2020
-
负责人:Sandeep Kasoji
-
依托单位:
Improving diagnostic sensitivity for difficult-to-lyse microbial samples with nanodroplet technology
-
批准号:10628013
-
项目类别:
-
资助金额:$99.84万
-
财政年份:2020
-
负责人:Sandeep Kasoji
-
依托单位:
Commercialization of cavitation-enhancing nanodroplets for DNA sample fragmentation in NGS applications
-
批准号:10259765
-
项目类别:
-
资助金额:$115.47万
-
财政年份:2018
-
负责人:Sandeep Kasoji
-
依托单位:
海外基金